Key Product Details
Description: | Potent and selective ROCK inhibitor |
Chemical Name: | N-[3-[[2-(4-Amino-1,2,5-oxadiazol-3-yl)-1-ethyl-1H-imidazo[4,5-c]pyridin-6-yl]oxy]phenyl]-4-[2-(4-morpholinyl)ethoxy]benzamide |
Purity: | ≥99% (HPLC) |
Molecular Weight: | 570.6 |
Customers also Viewed
Citations for GSK 269962 (6)
Citations are publications that use Bio-Techne products. Selected citations for GSK 269962 include:
-
Jiang et al.
(2017)
Determining the contents and cell origins of apoptotic bodies by flow cytometry.
Sci Rep.
7:14444
PMID: 29089562 -
Han et al.
(2016)
Macrophages redirect phagocytosis by non-professional phagocytes and influence inflammation
Nature.
539:570
PMID: 27820945 -
Lotz-Jenne et al.
(2016)
A high-content EMT screen identifies multiple receptor tyrosine kinase inhibitors with activity on TGFβ receptor.
Oncotarget.
7:25983
PMID: 27036020 -
Galea et al.
(2015)
Planar cell polarity aligns osteoblast division in response to substrate strain.
Stem Cell Res Ther.
30:423
PMID: 25264362 -
Evron et al.
(2014)
G Protein and β-arrestin signaling bias at the ghrelin receptor.
J Biol Chem.
289:33442
PMID: 25261469 -
Hutchinson et al.
(2014)
Lipopolysaccharide promotes contraction of uterine myocytes via activation of Rho/ROCK signaling pathways.
FASEB J.
28:94
PMID: 24076962
There are no citations that match your criteria.